MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on advancing precision cardiorenal care in critical ...
Taysha Gene Therapies, Inc. announced the granting of stock options to two new employees, totaling 401,000 shares of common stock, as part of their employment package. These options were granted under ...
Olema Pharmaceuticals, Inc. announced the grant of stock options to 11 new employees, allowing them to purchase a total of 322,000 shares of common stock, effective June 2, 2025. This move, approved ...
SAN DIEGO, Dec. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results